Arsenal buys pharma co from Wyeth for $81m
The New York firm acquires Scientific Protein Laboratories, a maker of ingredients for end-use pharmaceuticals, in its fifth portfolio acquisition for its debut fund, closed last June.
The New York firm acquires Scientific Protein Laboratories, a maker of ingredients for end-use pharmaceuticals, in its fifth portfolio acquisition for its debut fund, closed last June.
Copyright PEI Media
Not for publication, email or dissemination